Cytokinetics Inc Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 4 trades in Cytokinetics Inc (NASDAQ: CYTK) since 2025, across 2 members, worth an estimated $32.00K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 3 buys against 1 sell, a modestly buy-led skew, with Democratic members responsible for 50% of the trades and Republican members 50%. The most recent disclosure shown was filed July 2026, and Gilbert Cisneros has filed the most CYTK transactions among those shown, with 2. One notable disclosed move was a purchase by Gilbert Cisneros on October 9, 2025, up 28.4% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. Cytokinetics Inc's current Quantellect Tide Score is 31 out of 100 (Calm Tide), Bottom 17% of universe (3876); the Tide Score is generated algorithmically from public filings and market data and is not investment advice. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Cytokinetics Inc (CYTK) stock overview and the complete trade table below.
Data updated
Price & congressional trade timeline
Party breakdown
Cytokinetics congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | Owner | |
|---|---|---|---|---|---|---|---|---|
 Gilbert Cisneros House | Jul 2, 2026 | Jun 30, 2026 | 2 days | BUY |  $1,001 - $15,000 | -9.07% | Self | |
Gilbert Cisneros House | Nov 18, 2025 | Oct 9, 2025 | 40 days | BUY | $1,001 - $15,000 | +28.44% | Self |
Cytokinetics (CYTK) congressional trading FAQ
Can members of Congress legally trade Cytokinetics (CYTK) stock?
Yes. Members of Congress are permitted to trade individual stocks, including Cytokinetics (CYTK), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; it does not imply any trade was improper.
Are congressional Cytokinetics (CYTK) trades public?
Yes. Every congressional trade in Cytokinetics (CYTK) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded Cytokinetics (CYTK)?
Members of Congress have disclosed 4 trades in Cytokinetics (CYTK) worth $32.00K across 2 members, according to public STOCK Act filings.
Which members of Congress have traded Cytokinetics (CYTK)?
Recent and active filers of Cytokinetics (CYTK) disclosures include Gilbert Cisneros. The full member-by-member trade list is on this page.
Do Democrats or Republicans trade Cytokinetics (CYTK) more?
Across disclosed Cytokinetics (CYTK) trades, 50% were by Democrats and 50% by Republicans, so it is an even split.
What is the most recent congressional Cytokinetics (CYTK) trade?
The most recent disclosed Cytokinetics (CYTK) trade was a purchase by Gilbert Cisneros, filed Jul 1, 2026.
What is Cytokinetics (CYTK)'s Tide Score?
Cytokinetics (CYTK) has a Quantellect Tide Score of 31 (Calm Tide). The Tide Score is a 0-100 read blending price forecast, smart-money flow, technicals, and social sentiment; higher is more bullish.
Browse all stocks Congress tradesCongressional trading overviewCytokinetics (CYTK) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.